copy of dr. english on mirvetuximab soravtansine in ovarian cancer
Published 5 years ago • 43 plays • Length 0:26Download video MP4
Download video MP3
Similar videos
-
1:59
dr. english on mirvetuximab soravtansine in ovarian cancer
-
1:13
dr. o’malley on the activity of mirvetuximab soravtansine in ovarian cancer
-
1:49
dr. moore on safety profile of mirvetuximab soravtansine in ovarian cancer
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
1:41
dr. moore on benefit of mirvetuximab soravtansine in patients with ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
0:58
dr. o’malley on the utility of mirvetuximab in ovarian cancer
-
0:22
copy of dr. willmott on mechanisms of resistance in ovarian cancer
-
1:47
mirvetuximab soravtansine remains well tolerated in platinum-resistant ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
7:40
i/o combination strategies in ovarian cancer
-
1:23
dr. memarzadeh on p53 reactivation in ovarian cancer
-
0:51
dr. o'malley on folate-receptor alpha as a biomarker in ovarian cancer
-
1:05
dr. memarzadeh on recurrence rates in ovarian cancer
-
4:41
the researchers who are changing the story of ovarian cancer
-
3:23
medical english: diagnosis of ovarian cancer
-
0:48
detection - ovarian cancer answers
-
5:03
forward i: mirvetuximab soravtansine vs chemo in platinum-resistant ovarian cancer
-
1:56
elizabeth stover, md, phd, on gynecologic cancer treatment | dana-farber cancer institute